Quadrant Capital Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-372
| Closed | -$58K | – | 1430 |
|
|
2025
Q1 | $58K | Sell |
372
-21
| -5% | -$3.27K | ﹤0.01% | 1666 |
|
|
2024
Q4 | $54.1K | Buy |
393
+58
| +17% | +$7.99K | ﹤0.01% | 1371 |
|
|
2024
Q3 | $50K | Sell |
335
-7
| -2% | -$1.05K | ﹤0.01% | 1456 |
|
|
2024
Q2 | $46.6K | Buy |
342
+11
| +3% | +$1.5K | ﹤0.01% | 1445 |
|
|
2024
Q1 | $50K | Buy |
331
+13
| +4% | +$1.97K | ﹤0.01% | 1402 |
|
|
2023
Q4 | $40.1K | Buy |
318
+151
| +90% | +$19K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $15.6K | Sell |
167
-29
| -15% | -$2.72K | ﹤0.01% | 1809 |
|
|
2023
Q2 | $17.5K | Sell |
196
-83
| -30% | -$7.41K | ﹤0.01% | 1778 |
|
|
2023
Q1 | $29.9K | Sell |
279
-71
| -20% | -$7.61K | ﹤0.01% | 1494 |
|
|
2022
Q4 | $42.7K | Buy |
350
+71
| +25% | +$8.67K | ﹤0.01% | 1255 |
|
|
2022
Q3 | $29K | Buy |
279
+104
| +59% | +$10.8K | ﹤0.01% | 1336 |
|
|
2022
Q2 | $16K | Sell |
175
-30
| -15% | -$2.74K | ﹤0.01% | 1405 |
|
|
2022
Q1 | $24K | Sell |
205
-59
| -22% | -$6.91K | ﹤0.01% | 1238 |
|
|
2021
Q4 | $36K | Buy |
264
+51
| +24% | +$6.96K | ﹤0.01% | 1041 |
|
|
2021
Q3 | $34K | Buy |
213
+41
| +24% | +$6.55K | ﹤0.01% | 1007 |
|
|
2021
Q2 | $23K | Buy |
172
+102
| +146% | +$13.6K | ﹤0.01% | 1135 |
|
|
2021
Q1 | $9K | Buy |
70
+26
| +59% | +$3.34K | ﹤0.01% | 1525 |
|
|
2020
Q4 | $7K | Buy |
44
+17
| +63% | +$2.71K | ﹤0.01% | 1545 |
|
|
2020
Q3 | $4K | Buy |
27
+1
| +4% | +$148 | ﹤0.01% | 1603 |
|
|
2020
Q2 | $4K | Buy |
+26
| New | +$4K | ﹤0.01% | 1715 |
|